These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T, Sasa E. Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4915308 [No Abstract] [Full Text] [Related]
4. [Arteriosclerosis with special reference to anticholesteremic agents]. Murakami M, Sekimoto H, Nakada I, Takegoshi T, Iwaki N. Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239 [No Abstract] [Full Text] [Related]
5. [Treatment of arteriosclerosis by Atromid]. Ayad H. Rev Med Moyen Orient; 1967 Jun; 24(6):504-11. PubMed ID: 5264185 [No Abstract] [Full Text] [Related]
7. [The treatment of essential hyperlipidemia with clofibrate]. Reuter W, Seifert A. Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:184-7. PubMed ID: 4918619 [No Abstract] [Full Text] [Related]
8. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia. Howard AN, Hyams DE. Br Med J; 1971 Jul 03; 3(5765):25-7. PubMed ID: 4933388 [Abstract] [Full Text] [Related]
12. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate). Bergqvist N. Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978 [No Abstract] [Full Text] [Related]